IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation
Th17 cells are a common pathogenic effector cell in autoimmune inflammatory diseases. Here the authors show that the transcription factor RFX1 limits Th17 differentiation and is protective against the pathogenesis of Th17-driven autoimmune diseases.
Guardado en:
Autores principales: | Ming Zhao, Yixin Tan, Qiao Peng, Cancan Huang, Yu Guo, Gongping Liang, Bochen Zhu, Yi Huang, Aiyun Liu, Zijun Wang, Mengying Li, Xiaofei Gao, Ruifang Wu, Haijing Wu, Hai Long, Qianjin Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/924f8474ce9e432faa72f6e2dc568917 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ssu72 attenuates autoimmune arthritis via targeting of STAT3 signaling and Th17 activation
por: Seung Hoon Lee, et al.
Publicado: (2017) -
CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis
por: Hongli Li, et al.
Publicado: (2021) -
Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance
por: Kashyap A. Patel, et al.
Publicado: (2017) -
Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
por: Helena S Domingues, et al.
Publicado: (2010) -
The role of epigenetic mechanisms and processes in autoimmune disorders
por: Greer JM, et al.
Publicado: (2012)